Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
European Urology
|
January 1, 1997
5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trial
J Breul, G Jakse, G Forster, et al.
Urologia Internationalis
|
April 27, 2000
Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist
C Hofer, P Sauerstein, C Wolter, et al.
European Urology
|
June 12, 1999
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy
C Hofer, C Laubenbacher, T Block, et al.
World Journal of Surgery
|
November 9, 2000
New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: theoretic and practical aspects
C Hofer, R Hartung, R Göbel, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology
|
August 1, 1994
High resolution image-cytometric differentiation of hormone sensitive and hormone insensitive prostatic carcinomas
U Schenck, G Burger, U Jütting, et al.
The Journal of Pathology
|
April 1, 1994
Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes
H Zitzelsberger, S Szücs, H U Weier, et al.
The Journal of Gene Medicine
|
May 22, 2007
Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trial
T H Brill, H R Kübler, H von Randenborgh, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
European Urology
|
January 1, 1997
5-Fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: a prospective randomized pilot trial
J Breul, G Jakse, G Forster, et al.
Urologia Internationalis
|
April 27, 2000
Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist
C Hofer, P Sauerstein, C Wolter, et al.
European Urology
|
June 12, 1999
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy
C Hofer, C Laubenbacher, T Block, et al.
World Journal of Surgery
|
November 9, 2000
New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha: theoretic and practical aspects
C Hofer, R Hartung, R Göbel, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology
|
August 1, 1994
High resolution image-cytometric differentiation of hormone sensitive and hormone insensitive prostatic carcinomas
U Schenck, G Burger, U Jütting, et al.
The Journal of Pathology
|
April 1, 1994
Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes
H Zitzelsberger, S Szücs, H U Weier, et al.
The Journal of Gene Medicine
|
May 22, 2007
Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trial
T H Brill, H R Kübler, H von Randenborgh, et al.
Page
of 4